These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 8746195)
61. Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression. Polyakova V; Hein S; Kostin S; Ziegelhoeffer T; Schaper J J Am Coll Cardiol; 2004 Oct; 44(8):1609-18. PubMed ID: 15489093 [TBL] [Abstract][Full Text] [Related]
62. Collagen VI in the extracellular matrix of normal and failing human myocardium. Mollnau H; Münkel B; Schaper J Herz; 1995 Apr; 20(2):89-94. PubMed ID: 7774870 [TBL] [Abstract][Full Text] [Related]
63. Extracellular matrix biology: a new frontier in linking the pathology and therapy of hypertension? Tayebjee MH; MacFadyen RJ; Lip GY J Hypertens; 2003 Dec; 21(12):2211-8. PubMed ID: 14654734 [TBL] [Abstract][Full Text] [Related]
64. Cardiac fibroblasts: from development to heart failure. Moore-Morris T; Guimarães-Camboa N; Yutzey KE; Pucéat M; Evans SM J Mol Med (Berl); 2015 Aug; 93(8):823-30. PubMed ID: 26169532 [TBL] [Abstract][Full Text] [Related]
65. Reverse remodeling following insertion of left ventricular assist devices (LVAD): a review of the morphological and molecular changes. Wohlschlaeger J; Schmitz KJ; Schmid C; Schmid KW; Keul P; Takeda A; Weis S; Levkau B; Baba HA Cardiovasc Res; 2005 Dec; 68(3):376-86. PubMed ID: 16024006 [TBL] [Abstract][Full Text] [Related]
66. Fibroblasts: The arbiters of extracellular matrix remodeling. DeLeon-Pennell KY; Barker TH; Lindsey ML Matrix Biol; 2020 Sep; 91-92():1-7. PubMed ID: 32504772 [TBL] [Abstract][Full Text] [Related]
68. ECM remodeling in hypertensive heart disease. Berk BC; Fujiwara K; Lehoux S J Clin Invest; 2007 Mar; 117(3):568-75. PubMed ID: 17332884 [TBL] [Abstract][Full Text] [Related]
69. Cardiac remodeling and failure From molecules to man (Part II). Fedak PW; Verma S; Weisel RD; Li RK Cardiovasc Pathol; 2005; 14(2):49-60. PubMed ID: 15780796 [TBL] [Abstract][Full Text] [Related]
70. [Immune mechanisms in pathogenesis of chronic heart failure]. Egorova EN; Kalinkin MN; Mazur ES Patol Fiziol Eksp Ter; 2012; (2):56-61. PubMed ID: 22708411 [TBL] [Abstract][Full Text] [Related]
71. The lonely failing heart: a case for ECM genes. Weber KT Cardiovasc Res; 1995 Dec; 30(6):835. PubMed ID: 8746195 [No Abstract] [Full Text] [Related]
72. [Pathophysiology of cytoskeleton and extracellular matrix in failing myocardium]. Hori M; Sato H; Fukunami M; Houki N Nihon Rinsho; 1993 May; 51(5):1191-7. PubMed ID: 8331786 [TBL] [Abstract][Full Text] [Related]
73. [Molecular, genetic, and cellular aspects of the heart and vessel remodeling in hypertension (review)]. Shliakhto EV; Konradi AO; Moiseeva OM Ter Arkh; 2004; 76(6):51-8. PubMed ID: 15332577 [No Abstract] [Full Text] [Related]
74. Extracellular matrix dynamics in heart failure: a prospect for gene therapy. Tyagi SC J Cell Biochem; 1998 Mar; 68(4):403-10. PubMed ID: 9493904 [TBL] [Abstract][Full Text] [Related]